ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

INTEREST 2011 - 5th INTEREST Workshop



VenueDar es Sal, Tanzania Tanzania



Topics/Call fo Papers

General guidelines

Abstracts should contain the following four components:

Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included.
The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors may submit their abstracts electronically per 1 February using the button on the right. This will direct you to the appropriate webpage.
Please follow the step-by-step directions to upload the abstract file from your computer to our system. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Antiretroviral treatment scale up
Antiretroviral drug trials and regimens (1st, 2nd and 3rd line)
Antiretroviral treatment toxicities
Basic science
CNS disease
Health systems and HIV
High risk populations: epidemiology and prevention
HIV and other STD’s
HIV drug resistance
HIV epidemiology
HIV/hepatitis virus co-infection
HIV/malaria co-infection
HIV/TB co-infection
HIV Prevention
HIV vaccines
Information systems
Laboratory monitoring, including low cost technologies
Mental health and HIV
OI prophylaxis
Operational research on HIV programs
Pediatric HIV
Prevention of Mother-to-Child Transmission of HIV
Women and HIV

Notification of abstract acceptance and presentation format
Notification of acceptance and the requested format of presentation (oral or poster presentation) will be e-mailed (or faxed if you did not supply an e-mail address) to submitting authors mid-March. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Please notify the Conference Secretariat if you have not received notification end-March.

If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled. An Abstract Submitter’s Registration Form will be sent together with the notification to be used by the attending author to apply for the regular registration fee. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Final Program and Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Virology Education B.V.
Biltstraat 106
3572 BJ Utrecht
The Netherlands
P: +31 (0)30 230 7140
F: +31 (0)30 230 7148

Chamber of Commerce Utrecht, nr 30171841 ? VAT Number NL809658380B01

Last modified: 2011-01-31 11:24:08